FDA
FDA proposes changes to infant formula nutrient and labeling requirements
The proposed rule would revise minimum or maximum levels for four required nutrients, update certain units of measure and one permitted nutrient source, and amend required labeling. FDA also concluded that existing required levels remain appropriate for four other nutrients assessed.
Read the official sourceEMA
EMA publishes list of centrally authorized products with safety related information changes
EMA issued reference EMA/246449/2026, listing centrally authorized products with safety related changes to product information.
Read the official sourceMHRA
MHRA issues its October 2026 Safety Roundup
The roundup summarizes the latest safety advice for users of medicines and medical devices.
Read the official sourceMHRA
MHRA updates its list of registered orphan medicinal products
The authority published its list of authorized orphan medicinal products registered by the UK licensing authority.
Read the official sourceMHRA
MHRA approves triheptanoin for rare inherited disorders
MHRA approved triheptanoin (Dojolvi) to treat adult and pediatric patients with a group of rare inherited disorders.
Read the official sourceWhy this matters
Regulatory affairs teams should note the scope of FDA’s proposed nutrient and labeling revisions, while monitoring EMA and MHRA publications for current safety related product information, UK safety advice, and authorization records.
Scott Morvay
Founder, Gulfstream Intelligence
This brief provides general regulatory news and educational information. It is not legal or regulatory advice.